Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: a systematic review and economic evaluation

Bibliographic Details
Main Authors: C Green, J Dinnes, A Takeda, J Shepherd, D Hartwell, C Cave, E Payne, B Cuthbertson
Format: Article
Language:English
Published: NIHR Journals Library 2005-03-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta9110